Apogee Therapeutics

πŸ‘₯ 101-250πŸ’° $149,000,000 Series B about 3 years agoBiotechnologyTherapeuticsMedicalLife Science
Website LinkedIn

Apogee Therapeutics is a San Francisco-based biotechnology company, established in 2022, focused on developing innovative therapies for immunological and inflammatory disorders to meet patient needs.

Related companies:

Jobs at this company:

United StatesFull-TimeBiotechnologyPosted 11 days ago
LeadershipProject ManagementData Analysis+9 more
United StatesFull-TimeBiotechnologyPosted 14 days ago
LeadershipData AnalysisGCP+7 more
United StatesFull-TimeBiotechnologyPosted 1 month ago
LeadershipProject ManagementCross-functional Team Leadership+10 more
United StatesFull-TimeBiotechnologyPosted 1 month ago
Project ManagementSharePointCross-functional Team Leadership+7 more